201 related articles for article (PubMed ID: 22323881)
1. Clinical outcomes of cyclosporine treatment for noninfectious uveitis.
Lee SH; Chung H; Yu HG
Korean J Ophthalmol; 2012 Feb; 26(1):21-5. PubMed ID: 22323881
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis.
Joshi L; Talat L; Yaganti S; Sandhu S; Taylor SR; Wakefield D; McCluskey P; Lightman S
Ophthalmology; 2014 May; 121(5):1119-24. PubMed ID: 24433970
[TBL] [Abstract][Full Text] [Related]
3. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis.
Vitale AT; Rodriguez A; Foster CS
Ophthalmology; 1996 Mar; 103(3):365-73; discussion 373-4. PubMed ID: 8600411
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine for ocular inflammatory diseases.
Kaçmaz RO; Kempen JH; Newcomb C; Daniel E; Gangaputra S; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Foster CS
Ophthalmology; 2010 Mar; 117(3):576-84. PubMed ID: 20031223
[TBL] [Abstract][Full Text] [Related]
5. Low-dose cyclosporine treatment for sight-threatening uveitis: efficacy, toxicity, and tolerance.
Mathews D; Mathews J; Jones NP
Indian J Ophthalmol; 2010; 58(1):55-8. PubMed ID: 20029146
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A therapy in refractory non-infectious childhood uveitis.
Kilmartin DJ; Forrester JV; Dick AD
Br J Ophthalmol; 1998 Jul; 82(7):737-42. PubMed ID: 9924362
[TBL] [Abstract][Full Text] [Related]
7. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan JD; Rao MM; Ebert CD; Nguyen HH; Kim E; Porco TC; Acharya NR;
JAMA; 2019 Sep; 322(10):936-945. PubMed ID: 31503307
[TBL] [Abstract][Full Text] [Related]
8. Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.
Zaghetto JM; Yamamoto MM; Souza MB; Silva FT; Hirata CE; Olivalves E; Yamamoto JH
Arq Bras Oftalmol; 2010; 73(1):40-6. PubMed ID: 20464112
[TBL] [Abstract][Full Text] [Related]
9. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
10. Changing biological disease modifying treatment for paediatric uveitis in the real world.
Oh LJ; Nguyen CL; Phan K; Wong E; Zagora S; Singh-Grewal D; Chaitow J; Grigg JR; McCluskey P
Clin Exp Ophthalmol; 2019 Aug; 47(6):741-748. PubMed ID: 30834650
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine.
Sloper CM; Powell RJ; Dua HS
Ophthalmology; 1999 Apr; 106(4):723-8. PubMed ID: 10201592
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of chronic immunosuppression in patients with non-infectious uveitis.
Menezo V; Lau C; Comer M; Lightman S
Clin Exp Ophthalmol; 2005 Feb; 33(1):16-21. PubMed ID: 15670073
[TBL] [Abstract][Full Text] [Related]
13. Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
Heiligenhaus A; Zurek-Imhoff B; Roesel M; Hennig M; Rammrath D; Heinz C
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):143-52. PubMed ID: 23073842
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil as an immunomodulator in refractory noninfectious uveitis.
Rodriguez EE; Sakata VM; Cavalcanti DC; Zaghetto JM; Olivalves E; Hirata CE; Yamamoto JH
Arq Bras Oftalmol; 2016; 79(6):369-372. PubMed ID: 28076562
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis.
Park SE; Jun JW; Lee DH; Lee SC; Kim M
Yonsei Med J; 2021 Feb; 62(2):177-181. PubMed ID: 33527798
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
[TBL] [Abstract][Full Text] [Related]
18. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
[TBL] [Abstract][Full Text] [Related]
19. A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin.
Nussenblatt RB; de Smet MD; Rubin B; Freidlin V; Whitcup SM; Davis J; Herman D; Bloom JN; Sran PK; Whitcher S
Am J Ophthalmol; 1993 May; 115(5):583-91. PubMed ID: 8488909
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate for ocular inflammatory diseases.
Gangaputra S; Newcomb CW; Liesegang TL; Kaçmaz RO; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Kempen JH;
Ophthalmology; 2009 Nov; 116(11):2188-98.e1. PubMed ID: 19748676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
